Corporate Liaison and Ventures
Tuesday, October 24, 2023

Where Science Discoveries, Entrepreneurs, and Investors Converge

Get a sneak peek at the transformative biomedical research happening at Gladstone. Join the Industry Partnership Forum to talk to Gladstone scientists, learn more about research programs that are ready for translational opportunities, and discover how you can partner with our labs.

Presenting scientists will be available for a limited number of one-on-one meetings with both in-person and remote attendees. 

Program and Speakers

Time Speaker
10:00am Welcome
Ariel Brumbaugh, PhD, Biosciences Business Development Manager, Gladstone Institutes
10:05am Introduction to Gladstone
Deepak Srivastava, MD, President, Gladstone Institutes
10:10am Small Molecule Nav1.1 Enhancers to Improve Network Functions in Alzheimer’s Disease and Epilepsy 
Jorge Palop, PhD, Associate Investigator, Gladstone Institutes
Michael Pleiss, PhD, CNDAP Head of Medical Chemistry
Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes
10:35am Sprint Synthesis: Accelerating Biotechnology through a Novel Enzymatic DNA/RNA Synthesis Platform
Christina Palka, PhD, Visiting Scientist, Gladstone Institutes
Seth Shipman, PhD, Associate Investigator, Gladstone Institutes
11:00am Break
11:20am Operant BioPharma: Dynamic Drug Discovery in Live Cellular Biology with Artificial Intelligence
Drew Linsley, PhD, Assistant Professor of Research, Brown University
Jeremy Linsley, PhD, CSO, Operant Biopharma
Steve Finkbeiner, MD, PhD, Senior Investigator and Director, Center for Systems and Therapeutics, Gladstone Institutes
11:45am Function Bio: Accelerating Drug Discovery with Ultra-Deep CRISPR Scanning in Human Immune Cells 
Alex Marson, MD, PhD, Director, Gladstone-UCSF Institute of Genomic Immunology
12:10pm Lunch
12:55pm Synfini: Virtual and Physical, Closed-Loop Discovery with the Synfini Platform
Peter Madrid, PhD, Head of Scientific Development, Synfini
Nathan Collins, PhD, Head of Strategic Alliances and Development, Synfini
Doug Donzelli, CEO, Synfini
Isha Jain, Assistant Investigator, Gladstone Institutes
1:20pm ClpP Inhibitors for Obesity, Diabetes, and NAFLD
Yadong Huang, MD, PhD, Senior Investigator, Gladstone Institutes
1:45pm CELLutions for Neural Repair
Lana Zholudeva, PhD, Staff Research Scientist I, Gladstone Institutes 
Michael Lane, PhD, Associate Professor, Drexel University
2:10pm Break
2:30pm Blocking APOE Transcription as a Therapeutic Target for Alzheimer’s Disease
Jason Watts MD, PhD, NIEHS Earl Stadtman Investigator
Vivian Cheung MD, Professor, University of Michigan, Ann Arbor
Robert Mahley, MD, PhD, Senior Investigator and President Emeritus, Gladstone Institutes
Alecia Muth, MBA, Entrepreneur-in-Residence, Gladstone Institutes
2:55pm CRISPR Therapeutics for Dominant Neurological Disease
Bruce Conklin, MD, Senior Investigator, Gladstone Institutes
3:20pm Closing Remarks
Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes
3:30pm Networking Reception

Register to attend either in-person or virtually.


October 24, 2023
10:00am-5:00pm PDT
Mahley Auditorium, 1650 Owens Street, San Francisco, CA 94158 & Online
Public, Scientific

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.